Ectopic Heartbeat Clinical Trials

Find Ectopic Heartbeat Clinical Trials Near You

Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation - an International Multicenter Collaborative Study Group

Status: Recruiting
Location: See all (25) locations...
Study Type: Observational
SUMMARY

The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Centers : Centers participating in the present collaborative study group. Invitation to participate will be based either upon personal referral of one of the investigator, previous collaboration or based on a meta-analytic review of the literature published on the subject within the past 20 years.

• Patients: Females and males of \>18 years undergoing any type of VT/PVC ablation. While we will accept redo-procedure we will ask for a unique patient-identifier to link procedures belonging to the same patients together.

• Interventions: VT/PVC ablation (first intervention or re-do) as routinely performed by the participating centers

• Outcomes: Severe complications, defined as hemodynamic instability requiring mechanical intensive-care management, tamponade, stroke, cardiac arrest, myocardial infarction, phrenic nerve palsies, major bleeding requiring transfusion, vascular or cardiac complication requiring surgery, procedure-related death.

• Setting: Observational cohort studies, registries, retrospective cohort studies. Data stemming from RCTs (Randomized controlled trials) will not be collected as they likely do not represent a real-life setting.

• Length of follow-up: Peri-procedural complications

• Years considered: Not limited to a specific time-frame, but to reflect common ablation practices, we will focus on data from the 20 past years.

• Number of patients provided : No lower limit of patients provided per dataset or ablation volume per year to include high- as well as low-volume centers

Locations
United States
Illinois
Rush University Medical Center
RECRUITING
Chicago
Michigan
University of Michigan
RECRUITING
Michigan Center
Other Locations
Austria
Medical University of Graz
RECRUITING
Graz
Canada
Université Laval
RECRUITING
Québec
China
The First Affiliated Hospital of Nanjing Medical University
RECRUITING
Nanjing
Croatia
University Hospital Center Sestre milosrdnice
RECRUITING
Zagreb
France
CHU Bordeaux
RECRUITING
Bordeaux
Centre Hospitalier Universitaire Trousseau
RECRUITING
Chambray-lès-tours
University Hospital Poitier
RECRUITING
Poitiers
Clinique Pasteur Toulouse
RECRUITING
Toulouse
Germany
Zentralklinik Bad Bercka
RECRUITING
Bad Berka
Uniklinik Freiburg
RECRUITING
Bad Krozingen
Carl-Thiem-Klinikum
RECRUITING
Cottbus
Universitätsklinikum Münster
RECRUITING
Münster
Greece
University of Patras
RECRUITING
Pátrai
Israel
Sheba Medical Center
RECRUITING
Ramat Gan
Italy
Citta della Salute e della Scienza di Torino
RECRUITING
Torino
Singapore
Mount Elisabeth Medical Centre
RECRUITING
Singapore
Slovenia
University Medical Center Ljubljana
RECRUITING
Ljubljana
Spain
Hospital Universitario Ramón y Cajal
RECRUITING
Madrid
Switzerland
University Hospital Basel
RECRUITING
Basel
Inselspital Bern
RECRUITING
Bern
Turkey
Ankara City Hospital
RECRUITING
Ankara
Hacettepe University
RECRUITING
Ankara
United Kingdom
Royal Papworth Hospital
RECRUITING
Cambridge
Contact Information
Primary
Michael Kühne, Prof. Dr. med.
Michael.kuehne@usb.ch
0041 61 265 52 14
Backup
Patrick Badertscher, PD Dr. med.
Time Frame
Start Date: 2024-07-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 15000
Sponsors
Leads: University Hospital, Basel, Switzerland

This content was sourced from clinicaltrials.gov